The author argues that the rapid pace of technological change in the pharmaceutical industry has led to a loss of control over the production and distribution of drugs, resulting in a lack of transparency and accountability in the supply chain. The book examines the consequences of this lack of control, including the proliferation of counterfeit drugs, the rise of superbugs, and the decline of public trust in the medical establishment. The book also discusses the potential benefits of blockchain technology in addressing these issues, including increased transparency, traceability, and accountability in the supply chain. It presents a vision of a future where blockchain technology is used to create a decentralized, transparent, and secure system for tracking the origin, quality, and distribution of drugs, leading to improved patient outcomes and reduced healthcare costs. The author emphasizes the need for a personal paradigm shift in how we perceive the technological process of developing modern knowledge, one that prioritizes human values such as empathy, compassion, and social responsibility, rather than simply focusing on profit and efficiency. This shift would require a fundamental transformation of the way we approach innovation, with a focus on cooperation and collaboration between stakeholders, rather than competition and secrecy.

''